Compounds > disulfiram

disulfiram and abacavir

disulfiram has been researched along with abacavir in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	3 (50.00)	24.3611
2020's	2 (33.33)	2.80

Authors

Authors	Studies
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Barber, TJ; Mackie, NE; Marett, B; Portsmouth, S; Waldron, S; Weston, R; Winston, A	1

Reviews

1 review(s) available for disulfiram and abacavir

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

5 other study(ies) available for disulfiram and abacavir

Article	Year
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Perspectives on SARS-CoV-2 Main Protease Inhibitors. Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23 Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors	2021
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Are disulfiram-like reactions associated with abacavir-containing antiretroviral regimens in clinical practice? AIDS (London, England), 2007, Aug-20, Volume: 21, Issue:13 Topics: Adult; Alcohol Drinking; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Disulfiram; Ethanol; HIV Infections; Humans; Male; Reverse Transcriptase Inhibitors	2007